{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T20:57:20Z","timestamp":1791665840624,"version":"4.3.4"},"reference-count":194,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100002848","name":"CONICYT","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002848","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jcehepatology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical and Experimental Hepatology"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.jceh.2022.02.001","type":"journal-article","created":{"date-parts":[[2022,2,12]],"date-time":"2022-02-12T03:12:28Z","timestamp":1644635548000},"page":"1333-1348","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":65,"title":["Current Medical Treatment for Alcohol-Associated Liver Disease"],"prefix":"10.1016","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8651-2255","authenticated-orcid":false,"given":"Gustavo","family":"Ayares","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Idalsoaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis A.","family":"D\u00edaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Arnold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan P.","family":"Arab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jceh.2022.02.001_bib2","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1053\/j.gastro.2011.09.002","article-title":"Alcoholic liver disease: pathogenesis and new therapeutic targets","volume":"141","author":"Gao","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jceh.2022.02.001_bib3","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.jhep.2018.03.018","article-title":"Electronic address: easloffice@easloffice.eu, European association for the\u00a0study of the liver. EASL clinical practice guidelines: management of alcohol-related liver disease","volume":"69","year":"2018","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2022.02.001_bib4","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/hep.30866","article-title":"Diagnosis and treatment of alcohol-associated liver diseases: 2019 practice guidance from the American association for the study of liver diseases","volume":"71","author":"Crabb","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2022.02.001_bib5","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.aohep.2019.04.005","article-title":"Alcohol-related liver disease: clinical practice guidelines by the Latin American association for the study of the liver (ALEH)","volume":"18","author":"Arab","year":"2019","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.jceh.2022.02.001_bib6","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1111\/add.13757","article-title":"The relationship between different dimensions of alcohol use and the burden of disease-an update","volume":"112","author":"Rehm","year":"2017","journal-title":"Addiction"},{"key":"10.1016\/j.jceh.2022.02.001_bib7","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1177\/21650799211026980","article-title":"Dietary guidelines for Americans, 2020-2025","volume":"69","author":"Phillips","year":"2021","journal-title":"Workplace Health & Saf"},{"key":"10.1016\/j.jceh.2022.02.001_bib8","article-title":"Effect of increased alcohol consumption during COVID-19 pandemic on alcohol-related liver disease: a modeling study","author":"Julien","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2022.02.001_bib9","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1002\/hep4.1706","article-title":"COVID-19 aftershocks on alcohol-associated liver disease: an early cross-sectional report from the U.S. Epicenter","volume":"5","author":"Rutledge","year":"2021","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.jceh.2022.02.001_bib10","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1002\/hep4.1747","article-title":"Alcohol-associated liver disease before and after COVID-19-an overview and call for ongoing investigation","volume":"5","author":"Moon","year":"2021","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.jceh.2022.02.001_bib11","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.jceh.2020.04.017","article-title":"Telemedicine improves access to Hepatology consultation with\u00a0high patient satisfaction","volume":"10","author":"Mauro","year":"2020","journal-title":"J\u00a0Clin Exp Hepatol"},{"key":"10.1016\/j.jceh.2022.02.001_bib12","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S2468-1253(19)30415-7","article-title":"Outpatient management of alcohol-related liver disease","volume":"5","author":"Simonetto","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2022.02.001_bib13","series-title":"Diagnostic and Statistical Manual of Mental Disorders (DSM-5\u00ae)","year":"2013"},{"key":"10.1016\/j.jceh.2022.02.001_bib14","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/ajg.2017.469","article-title":"ACG clinical guideline: alcoholic liver disease","volume":"113","author":"Singal","year":"2018","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jceh.2022.02.001_bib15","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.jhep.2016.11.011","article-title":"Histological parameters and alcohol abstinence determine long-term prognosis in patients with alcoholic liver disease","volume":"66","author":"Lackner","year":"2017","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2022.02.001_bib16","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.jhep.2019.08.025","article-title":"Epidemiology and surveillance for hepatocellular carcinoma: new trends","volume":"72","author":"Singal","year":"2020","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2022.02.001_bib17","series-title":"Zakim and Boyer's Hepatology","first-page":"351","article-title":"Prevention and management of alcoholic liver disease","author":"Singal","year":"2018"},{"key":"10.1016\/j.jceh.2022.02.001_bib18","doi-asserted-by":"crossref","first-page":"12835","DOI":"10.3748\/wjg.v21.i45.12835","article-title":"Nutritional care in hospitalized patients with chronic liver disease","volume":"21","author":"Huynh","year":"2015","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jceh.2022.02.001_bib19","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1097\/MCG.0000000000001071","article-title":"Dietary interventions in liver cirrhosis","volume":"52","author":"Yao","year":"2018","journal-title":"J\u00a0Clin Gastroenterol"},{"key":"10.1016\/j.jceh.2022.02.001_bib20","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/ncpgasthep0443","article-title":"Nutritional support in patients with chronic liver disease","volume":"3","author":"Henkel","year":"2006","journal-title":"Nat Clin Pract Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2022.02.001_bib21","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1002\/hep.510230516","article-title":"Does malnutrition affect survival in cirrhosis? PINC (Policentrica Italiana Nutrizione Cirrosi)","volume":"23","author":"Merli","year":"1996","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2022.02.001_bib22","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.clnu.2006.02.007","article-title":"Introductory to the ESPEN guidelines on enteral nutrition: terminology, definitions and general topics","volume":"25","author":"Lochs","year":"2006","journal-title":"Clin Nutr"},{"key":"10.1016\/j.jceh.2022.02.001_bib23","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.clnu.2018.12.022","article-title":"ESPEN guideline on clinical nutrition in liver disease","volume":"38","author":"Plauth","year":"2019","journal-title":"Clin Nutr"},{"key":"10.1016\/j.jceh.2022.02.001_bib24","article-title":"Effect of sarcopenia on survival in patients with cirrhosis: a systematic review and meta-analysis","author":"Tantai","year":"2021","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2022.02.001_bib25","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.jceh.2017.11.001","article-title":"Nutrition and muscle in cirrhosis","volume":"7","author":"Anand","year":"2017","journal-title":"J\u00a0Clin Exp Hepatol"},{"key":"10.1016\/j.jceh.2022.02.001_bib26","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.cld.2012.08.009","article-title":"Nutrition in alcoholic liver disease","volume":"16","author":"Singal","year":"2012","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.jceh.2022.02.001_bib27","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/apt.15571","article-title":"Review article: malnutrition\/sarcopenia and frailty in patients with cirrhosis","volume":"51","author":"Bunchorntavakul","year":"2020","journal-title":"Aliment Pharmacol Ther"},{"issue":"Suppl 1","key":"10.1016\/j.jceh.2022.02.001_bib28","doi-asserted-by":"crossref","first-page":"S147","DOI":"10.1016\/j.jhep.2021.01.025","article-title":"Sarcopenia and frailty in decompensated cirrhosis","volume":"75","author":"Tandon","year":"2021","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2022.02.001_bib29","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1093\/ageing\/afy169","article-title":"Sarcopenia: revised European consensus on definition and diagnosis","volume":"48","author":"Cruz-Jentoft","year":"2019","journal-title":"Age Ageing"},{"key":"10.1016\/j.jceh.2022.02.001_bib30","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1002\/hep.32049","article-title":"Malnutrition, frailty, and sarcopenia in patients with cirrhosis: 2021 practice guidance by the American association for the study of liver diseases","volume":"74","author":"Lai","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2022.02.001_bib31","doi-asserted-by":"crossref","first-page":"4567","DOI":"10.3748\/wjg.v26.i31.4567","article-title":"Current understanding of the metabolism of micronutrients in chronic alcoholic liver disease","volume":"26","author":"Wu","year":"2020","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jceh.2022.02.001_bib32","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.cccn.2004.12.012","article-title":"Oxidative stress and antioxidant status in patients with alcoholic liver disease","volume":"355","author":"Masalkar","year":"2005","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.jceh.2022.02.001_bib33","doi-asserted-by":"crossref","first-page":"c1240","DOI":"10.1136\/bmj.c1240","article-title":"Effect of body mass index and alcohol consumption on liver disease: analysis of data from two prospective cohort studies","volume":"340","author":"Hart","year":"2010","journal-title":"BMJ"},{"key":"10.1016\/j.jceh.2022.02.001_bib34","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1002\/hep.29631","article-title":"Interaction between alcohol consumption and metabolic syndrome in predicting severe liver disease in the general population","volume":"67","author":"\u00c5berg","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2022.02.001_bib35","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.jhep.2017.11.006","article-title":"The bidirectional impacts of alcohol consumption and the metabolic syndrome: cofactors for progressive fatty liver disease","volume":"68","author":"Boyle","year":"2018","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2022.02.001_bib36","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.jceh.2020.09.003","article-title":"Nutrition in chronic liver disease: consensus statement of the Indian national association for study of the liver","volume":"11","author":"Puri","year":"2021","journal-title":"J\u00a0Clin Exp Hepatol"},{"key":"10.1016\/j.jceh.2022.02.001_bib37","doi-asserted-by":"crossref","first-page":"E875","DOI":"10.1503\/cmaj.191707","article-title":"Obesity in adults: a clinical practice guideline","volume":"192","author":"Wharton","year":"2020","journal-title":"CMAJ"},{"key":"10.1016\/j.jceh.2022.02.001_bib38","doi-asserted-by":"crossref","DOI":"10.1111\/jgh.13166","article-title":"Nonalcoholic steatohepatitis is strongly associated with sarcopenic obesity in patients with cirrhosis undergoing liver transplant evaluation","volume":"31","author":"Carias","year":"2016","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2022.02.001_bib39","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1093\/ajcn\/81.4.903","article-title":"Adipose tissue in muscle: a novel depot similar in size to visceral adipose tissue","volume":"81","author":"Gallagher","year":"2005","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.jceh.2022.02.001_bib40","doi-asserted-by":"crossref","first-page":"3533","DOI":"10.1016\/j.clnu.2020.09.001","article-title":"ESPEN practical guideline: clinical nutrition in liver disease","volume":"39","author":"Bischoff","year":"2020","journal-title":"Clin Nutr"},{"key":"10.1016\/j.jceh.2022.02.001_bib42","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0261-5614(02)00214-5","article-title":"Nutritional risk screening (NRS 2002): a new method based on an analysis of controlled clinical trials","volume":"22","author":"Kondrup","year":"2003","journal-title":"Clin Nutr"},{"key":"10.1016\/j.jceh.2022.02.001_bib43","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.clnu.2008.03.012","article-title":"EuroOOPS: an international, multicentre study to implement nutritional risk screening and evaluate clinical outcome","volume":"27","author":"Sorensen","year":"2008","journal-title":"Clin Nutr"},{"key":"10.1016\/j.jceh.2022.02.001_bib44","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1017\/S0007114520002366","article-title":"Royal Free Hospital-Nutritional Prioritizing Tool improves the prediction of malnutrition risk outcomes in liver cirrhosis patients compared with Nutritional Risk Screening 2002","volume":"124","author":"Wu","year":"2020","journal-title":"Br J Nutr"},{"key":"10.1016\/j.jceh.2022.02.001_bib45","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1007\/s10620-015-4015-z","article-title":"The royal free hospital-nutritional prioritizing tool is an independent predictor of deterioration of liver function and survival in cirrhosis","volume":"61","author":"Borhofen","year":"2016","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jceh.2022.02.001_bib46","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1002\/hep.29003","article-title":"A\u00a0practical approach to nutritional screening and assessment in cirrhosis","volume":"65","author":"Tandon","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2022.02.001_bib47","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1002\/hep.30828","article-title":"A\u00a0north American expert opinion statement on sarcopenia in liver transplantation","volume":"70","author":"Carey","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2022.02.001_bib48","doi-asserted-by":"crossref","first-page":"3049","DOI":"10.1016\/j.clnu.2020.01.008","article-title":"Automated body composition analysis of clinically acquired computed tomography scans using neural networks","volume":"39","author":"Paris","year":"2020","journal-title":"Clin Nutr"},{"key":"10.1016\/j.jceh.2022.02.001_bib49","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1002\/lt.24750","article-title":"A\u00a0multicenter study to define sarcopenia in patients with end-stage liver disease","volume":"23","author":"Carey","year":"2017","journal-title":"Liver Transplant"},{"key":"10.1016\/j.jceh.2022.02.001_bib50","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1152\/jappl.1998.85.1.115","article-title":"Cadaver validation of skeletal muscle measurement by magnetic resonance imaging and computerized tomography","volume":"85","author":"Mitsiopoulos","year":"1998","journal-title":"J\u00a0Appl Physiol"},{"key":"10.1016\/j.jceh.2022.02.001_bib51","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1002\/hep.27830","article-title":"Standard assessments of frailty are validated predictors of mortality in hospitalized patients with cirrhosis","volume":"62","author":"Tapper","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2022.02.001_bib52","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.jhep.2018.05.025","article-title":"Karnofsky performance status before and after liver transplantation predicts graft and patient survival","volume":"69","author":"Thuluvath","year":"2018","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2022.02.001_bib53","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1002\/hep.28900","article-title":"A\u00a0Karnofsky performance status-based score predicts death after hospital discharge in patients with cirrhosis","volume":"65","author":"Tandon","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2022.02.001_bib54","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1002\/jcsm.12095","article-title":"Malnutrition and sarcopenia predict post-liver transplantation outcomes independently of the Model for End-stage Liver Disease score","volume":"8","author":"Kalafateli","year":"2017","journal-title":"J\u00a0Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.jceh.2022.02.001_bib55","first-page":"CD008344","article-title":"Nutritional support for liver disease","volume":"5","author":"Koretz","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jceh.2022.02.001_bib56","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1111\/apt.12252","article-title":"Meta-analysis: oral or enteral nutritional supplementation in cirrhosis","volume":"37","author":"Ney","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jceh.2022.02.001_bib57","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1053\/j.gastro.2015.12.038","article-title":"Intensive enteral nutrition is ineffective for patients with severe alcoholic hepatitis treated with corticosteroids","volume":"150","author":"Moreno","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jceh.2022.02.001_bib58","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.cgh.2015.09.028","article-title":"Efficacy of nutritional therapy for patients with cirrhosis and minimal hepatic encephalopathy in a randomized trial","volume":"14","author":"Maharshi","year":"2016","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2022.02.001_bib59","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.gastrohep.2012.03.001","article-title":"[Nutritional support in patients with liver cirrhosis]","volume":"35","author":"Rivera Irigoin","year":"2012","journal-title":"Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2022.02.001_bib60","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1002\/hep.22367","article-title":"Nocturnal nutritional supplementation improves total body protein status of patients with liver cirrhosis: a randomized 12-month trial","volume":"48","author":"Plank","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2022.02.001_bib61","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1136\/bmj.299.6709.1202","article-title":"Effect of a late evening meal on nitrogen balance in patients with cirrhosis of the liver","volume":"299","author":"Swart","year":"1989","journal-title":"BMJ"},{"key":"10.1016\/j.jceh.2022.02.001_bib62","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/S0168-8278(05)80221-1","article-title":"Nocturnal oral glucose supplementation. The effects on protein metabolism in cirrhotic patients and in healthy controls","volume":"17","author":"Zillikens","year":"1993","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2022.02.001_bib63","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1111\/j.1440-1746.2011.06951.x","article-title":"Late evening snack: exploiting a period of anabolic opportunity in cirrhosis","volume":"27","author":"Tsien","year":"2012","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2022.02.001_bib64","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1007\/BF02774169","article-title":"Effect of long-term oral supplementation with branched-chain amino acid granules on the prognosis of liver cirrhosis","volume":"24","author":"Yoshida","year":"1989","journal-title":"Gastroenterol Jpn"},{"key":"10.1016\/j.jceh.2022.02.001_bib65","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/S1542-3565(05)00017-0","article-title":"Effects of oral branched-chain amino acid granules on event-free survival in patients with liver cirrhosis","volume":"3","author":"Muto","year":"2005","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2022.02.001_bib66","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1002\/hep.24412","article-title":"Branched-chain amino acids as pharmacological nutrients in chronic liver disease","volume":"54","author":"Kawaguchi","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2022.02.001_bib67","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1016\/S0016-5085(03)00323-8","article-title":"Nutritional supplementation with branched-chain amino acids in advanced cirrhosis: a double-blind, randomized trial","volume":"124","author":"Marchesini","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jceh.2022.02.001_bib68","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.clnu.2005.02.010","article-title":"Effects of an appropriate oral diet on the nutritional status of patients with HCV-related liver cirrhosis: a prospective study","volume":"24","author":"Manguso","year":"2005","journal-title":"Clin Nutr"},{"key":"10.1016\/j.jceh.2022.02.001_bib69","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1079\/BJN19950158","article-title":"Long-term oral refeeding of patients with cirrhosis of the liver","volume":"74","author":"Nielsen","year":"1995","journal-title":"Br J Nutr"},{"key":"10.1016\/j.jceh.2022.02.001_bib70","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.rgmx.2017.02.005","article-title":"Effect of a high-protein, high-fiber diet plus supplementation with branched-chain amino acids on the nutritional status of patients with cirrhosis","volume":"83","author":"Ruiz-Marg\u00e1in","year":"2018","journal-title":"Rev Gastroenterol M\u00e9xico"},{"key":"10.1016\/j.jceh.2022.02.001_bib71","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1002\/hep.1840040218","article-title":"Comparison of dietary protein with an oral, branched chain-enriched amino acid supplement in chronic portal-systemic encephalopathy: a randomized controlled trial","volume":"4","author":"Horst","year":"1984","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2022.02.001_bib72","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jhep.2004.03.023","article-title":"Normal protein diet for episodic hepatic encephalopathy: results of a randomized study","volume":"41","author":"C\u00f3rdoba","year":"2004","journal-title":"J\u00a0Hepatol"},{"issue":"Suppl 1","key":"10.1016\/j.jceh.2022.02.001_bib73","doi-asserted-by":"crossref","first-page":"S131","DOI":"10.1016\/j.jceh.2015.02.004","article-title":"Reprint of: nutrition in the management of cirrhosis and its neurological complications","volume":"5","author":"B\u00e9meur","year":"2015","journal-title":"J\u00a0Clin Exp Hepatol"},{"key":"10.1016\/j.jceh.2022.02.001_bib74","first-page":"1308","article-title":"Improvement in the nutritional status and clinical conditions of patients with liver failure using a liver diet combined with a branched chain amino acids-enriched elemental diet","volume":"61","author":"Matsuoka","year":"2014","journal-title":"Hepato-Gastroenterology"},{"key":"10.1016\/j.jceh.2022.02.001_bib75","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1093\/ajcn\/38.6.849","article-title":"Assessment of nutritional status and in\u00a0vivo immune responses in alcoholic liver disease","volume":"38","author":"Mills","year":"1983","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.jceh.2022.02.001_bib76","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1055\/s-2007-1007349","article-title":"Nutritional therapy in alcoholic liver disease","volume":"13","author":"Schenker","year":"1993","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.jceh.2022.02.001_bib77","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1080\/07315724.1991.10718182","article-title":"Alcohol, liver, and nutrition","volume":"10","author":"Lieber","year":"1991","journal-title":"J\u00a0Am Coll Nutr"},{"key":"10.1016\/j.jceh.2022.02.001_bib78","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1055\/s-2007-1007365","article-title":"Management of osteopenia of liver disease with special emphasis on primary biliary cirrhosis","volume":"13","author":"Lindor","year":"1993","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.jceh.2022.02.001_bib79","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1111\/liv.13691","article-title":"A\u00a0low muscle mass increases mortality in compensated cirrhotic patients with sepsis","volume":"38","author":"Lucidi","year":"2018","journal-title":"Liver Int"},{"key":"10.1016\/j.jceh.2022.02.001_bib80","first-page":"CD001939","article-title":"Branched-chain amino acids for people with hepatic encephalopathy","volume":"5","author":"Gluud","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jceh.2022.02.001_bib81","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1002\/lt.24607","article-title":"Low serum testosterone is associated with adverse outcome in men with cirrhosis independent of the model for end-stage liver disease score","volume":"22","author":"Sinclair","year":"2016","journal-title":"Liver Transplant"},{"key":"10.1016\/j.jceh.2022.02.001_bib82","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/j.jhep.2016.06.007","article-title":"Testosterone therapy increases muscle mass in men with cirrhosis and low testosterone: a randomised controlled trial","volume":"65","author":"Sinclair","year":"2016","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2022.02.001_bib83","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/BF01991779","article-title":"An international perspective on the prevalence of the Wernicke-Korsakoff syndrome","volume":"10","author":"Harper","year":"1995","journal-title":"Metab Brain Dis"},{"key":"10.1016\/j.jceh.2022.02.001_bib84","first-page":"381","article-title":"Wernicke's encephalopathy--prevalence and clinical spectrum","volume":"1","author":"Torvik","year":"1991","journal-title":"Alcohol Alcohol Suppl"},{"key":"10.1016\/j.jceh.2022.02.001_bib85","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1111\/j.1468-1331.2010.03153.x","article-title":"EFNS guidelines for diagnosis, therapy and prevention of Wernicke encephalopathy","volume":"17","author":"Galvin","year":"2010","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.jceh.2022.02.001_bib86","first-page":"CD004033","article-title":"Thiamine for prevention and treatment of Wernicke-Korsakoff Syndrome in people who abuse alcohol","volume":"7","author":"Day","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jceh.2022.02.001_bib87","doi-asserted-by":"crossref","first-page":"121","DOI":"10.4103\/psychiatry.IndianJPsychiatry_440_20","article-title":"High-dose thiamine strategy in Wernicke-Korsakoff syndrome and related thiamine deficiency conditions associated with alcohol use disorder","volume":"63","author":"Praharaj","year":"2021","journal-title":"Indian J Psychiatr"},{"key":"10.1016\/j.jceh.2022.02.001_bib88","article-title":"Clinical guideline highlights for the hospitalist: 2020 American society of addiction medicine clinical practice guideline on alcohol withdrawal management","author":"Ganatra","year":"2021","journal-title":"J\u00a0Hosp Med"},{"key":"10.1016\/j.jceh.2022.02.001_bib89","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1111\/imj.12522","article-title":"Thiamine in the treatment of Wernicke encephalopathy in patients with alcohol use disorders","volume":"44","author":"Latt","year":"2014","journal-title":"Intern Med J"},{"key":"10.1016\/j.jceh.2022.02.001_bib90","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1016\/j.cgh.2019.01.026","article-title":"Alcohol-related liver disease is rarely detected at early stages compared with liver diseases of other etiologies worldwide","volume":"17","author":"Shah","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2022.02.001_bib91","doi-asserted-by":"crossref","first-page":"869","DOI":"10.17235\/reed.2020.7242\/2020","article-title":"Alcoholic-related liver disease: pathogenesis, management and future therapeutic developments","volume":"112","author":"Argemi","year":"2020","journal-title":"Rev Esp Enferm Dig"},{"key":"10.1016\/j.jceh.2022.02.001_bib92","article-title":"The role of fibrosis index FIB-4 in predicting liver fibrosis stage and clinical prognosis: a diagnostic or screening tool?","author":"Xu","year":"2021","journal-title":"J\u00a0Formos Med Assoc"},{"key":"10.1016\/j.jceh.2022.02.001_bib93","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1002\/hep.30979","article-title":"Cost-effectiveness of noninvasive screening for alcohol-related liver fibrosis","volume":"71","author":"Asphaug","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2022.02.001_bib94","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.jhep.2018.11.025","article-title":"Non-invasive diagnosis and biomarkers in alcohol-related liver disease","volume":"70","author":"Moreno","year":"2019","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2022.02.001_bib95","doi-asserted-by":"crossref","first-page":"173","DOI":"10.5009\/gnl16477","article-title":"Pathophysiology and management of alcoholic liver disease: update 2016","volume":"11","author":"Stickel","year":"2017","journal-title":"Gut Liver"},{"key":"10.1016\/j.jceh.2022.02.001_bib96","first-page":"1","article-title":"Automatically detecting pain using facial actions","volume":"2009","author":"Lucey","year":"2009","journal-title":"Int Conf Affect Comput Intell Interact Workshops"},{"key":"10.1016\/j.jceh.2022.02.001_bib97","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1053\/j.gastro.2016.02.042","article-title":"Standard definitions and common data elements for clinical trials in patients with alcoholic hepatitis: recommendation from the NIAAA alcoholic hepatitis consortia","volume":"150","author":"Crabb","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jceh.2022.02.001_bib98","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jceh.2012.11.002","article-title":"Model for end-stage liver disease","volume":"3","author":"Singal","year":"2013","journal-title":"J\u00a0Clin Exp Hepatol"},{"key":"10.1016\/j.jceh.2022.02.001_bib99","doi-asserted-by":"crossref","first-page":"A76","DOI":"10.1016\/S0016-5085(08)80377-0","article-title":"A\u00a0model to predict survival in patients with end-stage liver disease","volume":"120","author":"Kamath","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jceh.2022.02.001_bib100","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.amjsurg.2004.07.034","article-title":"Child-Turcotte-Pugh versus MELD score as a predictor of outcome after elective and emergent surgery in cirrhotic patients","volume":"188","author":"Farnsworth","year":"2004","journal-title":"Am J Surg"},{"key":"10.1016\/j.jceh.2022.02.001_bib101","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/j.jhep.2021.06.019","article-title":"Identification of optimal therapeutic window for steroid use in severe alcohol-associated hepatitis: a worldwide study","volume":"75","author":"Arab","year":"2021","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2022.02.001_bib102","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.jhep.2004.12.022","article-title":"MELD score is a better prognostic model than Child-Turcotte-Pugh score or Discriminant Function score in patients with alcoholic hepatitis","volume":"42","author":"Srikureja","year":"2005","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2022.02.001_bib103","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1136\/gut.2010.224097","article-title":"Corticosteroids improve short-term survival in patients with severe alcoholic hepatitis: meta-analysis of individual patient data","volume":"60","author":"Mathurin","year":"2011","journal-title":"Gut"},{"key":"10.1016\/j.jceh.2022.02.001_bib104","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.jhep.2017.11.017","article-title":"Application of prognostic scores in the STOPAH trial: Discriminant function is no longer the optimal scoring system in alcoholic hepatitis","volume":"68","author":"Forrest","year":"2018","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2022.02.001_bib105","author":"Arraez"},{"key":"10.1016\/j.jceh.2022.02.001_bib106","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.14309\/ajg.0000000000000912","article-title":"In severe alcoholic hepatitis, serum keratin-18 fragments are diagnostic, prognostic, and theragnostic biomarkers","volume":"115","author":"Atkinson","year":"2020","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jceh.2022.02.001_bib107","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.jceh.2018.09.002","article-title":"Relative adrenal insufficiency in patients with alcoholic hepatitis","volume":"9","author":"Kumar","year":"2019","journal-title":"J\u00a0Clin Exp Hepatol"},{"key":"10.1016\/j.jceh.2022.02.001_bib108","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.cgh.2011.09.011","article-title":"Acute kidney injury is an early predictor of mortality for patients with alcoholic hepatitis","volume":"10","author":"Altamirano","year":"2012","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2022.02.001_bib109","doi-asserted-by":"crossref","first-page":"m2687","DOI":"10.1136\/bmj.m2687","article-title":"Hepatorenal syndrome: pathophysiology, diagnosis, and management","volume":"370","author":"Simonetto","year":"2020","journal-title":"BMJ"},{"key":"10.1016\/j.jceh.2022.02.001_bib110","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1136\/gutjnl-2014-308874","article-title":"Diagnosis and management of acute kidney injury in patients with cirrhosis: revised consensus recommendations of the International Club of Ascites","volume":"64","author":"Angeli","year":"2015","journal-title":"Gut"},{"key":"10.1016\/j.jceh.2022.02.001_bib111","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.jhep.2013.03.039","article-title":"Evaluation of the Acute Kidney Injury Network criteria in hospitalized patients with cirrhosis and ascites","volume":"59","author":"Piano","year":"2013","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2022.02.001_bib112","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1053\/j.gastro.2008.02.024","article-title":"Terlipressin and albumin vs albumin in patients with cirrhosis and hepatorenal syndrome: a randomized study","volume":"134","author":"Mart\u00edn-Llah\u00ed","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jceh.2022.02.001_bib113","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/S2468-1253(16)30157-1","article-title":"Comparative efficacy of pharmacological strategies for management of type 1 hepatorenal syndrome: a systematic review and network meta-analysis","volume":"2","author":"Facciorusso","year":"2017","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2022.02.001_bib114","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1111\/liv.13893","article-title":"Hepatorenal syndrome in the era of acute kidney injury","volume":"38","author":"Sol\u00e9","year":"2018","journal-title":"Liver Int"},{"key":"10.1016\/j.jceh.2022.02.001_bib115","doi-asserted-by":"crossref","first-page":"100236","DOI":"10.1016\/j.aohep.2020.07.008","article-title":"An integrated review of the hepatorenal syndrome","volume":"22","author":"Ojeda-Yuren","year":"2021","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.jceh.2022.02.001_bib116","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1002\/hep.21737","article-title":"Neutrophil dysfunction in alcoholic hepatitis superimposed on cirrhosis is reversible and predicts the outcome","volume":"46","author":"Mookerjee","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2022.02.001_bib117","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1136\/gutjnl-2015-310585","article-title":"Intestinal microbiota contributes to individual susceptibility to alcoholic liver disease","volume":"65","author":"Llopis","year":"2016","journal-title":"Gut"},{"key":"10.1016\/j.jceh.2022.02.001_bib118","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1128\/jb.172.1.155-163.1990","article-title":"Genetic analysis of the pAD1 hemolysin\/bacteriocin determinant in Enterococcus faecalis: tn917 insertional mutagenesis and cloning","volume":"172","author":"Ike","year":"1990","journal-title":"J\u00a0Bacteriol"},{"key":"10.1016\/j.jceh.2022.02.001_bib119","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/s41586-019-1742-x","article-title":"Bacteriophage targeting of gut bacterium attenuates alcoholic liver disease","volume":"575","author":"Duan","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.jceh.2022.02.001_bib120","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1053\/j.gastro.2016.12.019","article-title":"In patients with severe alcoholic hepatitis, prednisolone increases susceptibility to infection and infection-related mortality, and is associated with high\u00a0circulating levels of bacterial DNA","volume":"152","author":"Vergis","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jceh.2022.02.001_bib121","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1177\/1756283X11401774","article-title":"Rifaximin treatment for reduction of risk of overt hepatic encephalopathy recurrence","volume":"4","author":"Flamm","year":"2011","journal-title":"Therap Adv Gastroenterol"},{"key":"10.1016\/j.jceh.2022.02.001_bib122","series-title":"Clinical Hepatology","article-title":"IDDF2021-ABS-0089 Primary norfloxacin prophylaxis reduces the incidence of infections in severe alcoholic hepatitis-A double-blind, randomized controlled study","author":"Kulkarni","year":"2021"},{"key":"10.1016\/j.jceh.2022.02.001_bib123","doi-asserted-by":"crossref","DOI":"10.14309\/ctg.0000000000000306","article-title":"No effect in alcoholic hepatitis of gut-selective, broad-spectrum antibiotics on bacterial translocation or hepatic and systemic inflammation","volume":"12","author":"St\u00f8y","year":"2021","journal-title":"Clin Transl Gastroenterol"},{"key":"10.1016\/j.jceh.2022.02.001_bib125","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1053\/jhep.2000.19621","article-title":"Exacerbation of alcoholic liver injury by enteral endotoxin in rats","volume":"32","author":"Mathurin","year":"2000","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2022.02.001_bib126","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S0016-5085(98)70211-2","article-title":"Alcohol causes both tolerance and sensitization of rat Kupffer cells via mechanisms dependent on endotoxin","volume":"115","author":"Enomoto","year":"1998","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jceh.2022.02.001_bib127","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1093\/oxfordjournals.alcalc.a008123","article-title":"The treatment of alcoholic hepatitis","volume":"31","author":"Morgan","year":"1996","journal-title":"Alcohol Alcohol"},{"issue":"Suppl 1","key":"10.1016\/j.jceh.2022.02.001_bib128","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1159\/000341126","article-title":"Innate immunity and alcoholic liver disease","volume":"30","author":"Szabo","year":"2012","journal-title":"Dig Dis"},{"key":"10.1016\/j.jceh.2022.02.001_bib129","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1053\/j.gastro.2018.05.011","article-title":"Corticosteroids reduce risk of death within 28 Days for patients with severe alcoholic hepatitis, compared with pentoxifylline or placebo-a meta-analysis of individual data from controlled trials","volume":"155","author":"Louvet","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jceh.2022.02.001_bib130","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1053\/j.gastro.2014.01.018","article-title":"A\u00a0histologic scoring system for prognosis of patients with alcoholic hepatitis","volume":"146","author":"Altamirano","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jceh.2022.02.001_bib131","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/hep.23258","article-title":"Practice guideline committee of the American association for the study of liver diseases and the practice parameters committee of the American college of gastroenterology. Alcoholic liver disease","volume":"51","author":"O'Shea","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2022.02.001_bib132","first-page":"CD001511","article-title":"Glucocorticosteroids for people with alcoholic hepatitis","volume":"11","author":"Pavlov","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jceh.2022.02.001_bib133","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1001\/jama.2021.7683","article-title":"Diagnosis and treatment of alcohol-associated liver disease: a review","volume":"326","author":"Singal","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.jceh.2022.02.001_bib134","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1186\/1745-6215-14-262","article-title":"Steroids or pentoxifylline for alcoholic hepatitis (STOPAH): study protocol for a randomised controlled trial","volume":"14","author":"Forrest","year":"2013","journal-title":"Trials"},{"key":"10.1016\/j.jceh.2022.02.001_bib135","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1055\/s-0036-1571297","article-title":"Therapeutic strategies for the treatment of alcoholic hepatitis","volume":"36","author":"Singal","year":"2016","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.jceh.2022.02.001_bib136","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0016-5085(78)90401-8","article-title":"Corticosteroid therapy of alcoholic hepatitis","volume":"75","author":"Maddrey","year":"1978","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jceh.2022.02.001_bib137","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/BF01072499","article-title":"Adrenocorticosteroid therapy in alcoholic hepatitis. A prospective, double-blind randomized study","volume":"22","author":"Blitzer","year":"1977","journal-title":"Am J Dig Dis"},{"issue":"2 Pt 1","key":"10.1016\/j.jceh.2022.02.001_bib138","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/0016-5085(78)90790-4","article-title":"Treatment of alcoholic hepatitis with encephalopathy. Comparison of prednisolone with caloric supplements","volume":"74","author":"Lesesne","year":"1978","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jceh.2022.02.001_bib139","first-page":"443","article-title":"A\u00a0controlled trial of 6-methylprednisolone in acute alcoholic hepatitis. With a note on published results in encephalopathic patients","volume":"69","author":"Shumaker","year":"1978","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jceh.2022.02.001_bib140","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/0016-5085(80)90867-7","article-title":"Double-blind controlled trial of prednisolone therapy in patients with severe acute alcoholic hepatitis and spontaneous encephalopathy","volume":"78","author":"Depew","year":"1980","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jceh.2022.02.001_bib141","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1136\/gut.23.1.75","article-title":"Controlled trial of methylprednisolone therapy in severe acute alcoholic hepatitis","volume":"23","author":"Theodossi","year":"1982","journal-title":"Gut"},{"key":"10.1016\/j.jceh.2022.02.001_bib142","doi-asserted-by":"crossref","first-page":"685","DOI":"10.7326\/0003-4819-110-9-685","article-title":"Methylprednisolone therapy in patients with severe alcoholic hepatitis. A randomized multicenter trial","volume":"110","author":"Carithers","year":"1989","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jceh.2022.02.001_bib143","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1056\/NEJM199202203260802","article-title":"A\u00a0randomized trial of prednisolone in patients with severe alcoholic hepatitis","volume":"326","author":"Ramond","year":"1992","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jceh.2022.02.001_bib144","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1053\/jhep.2000.8627","article-title":"Short- and long-term outcome of severe alcohol-induced hepatitis treated with steroids or enteral nutrition: a multicenter randomized trial","volume":"32","author":"Cabr\u00e9","year":"2000","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2022.02.001_bib145","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.jhep.2005.11.039","article-title":"Antioxidants versus corticosteroids in the treatment of severe alcoholic hepatitis--a randomised clinical trial","volume":"44","author":"Phillips","year":"2006","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2022.02.001_bib146","doi-asserted-by":"crossref","first-page":"625","DOI":"10.7326\/0003-4819-79-5-625","article-title":"Prednisone therapy of acute alcoholic hepatitis. Report of a controlled trial","volume":"79","author":"Campra","year":"1973","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jceh.2022.02.001_bib147","doi-asserted-by":"crossref","first-page":"311","DOI":"10.7326\/0003-4819-74-3-311","article-title":"Alcoholic hepatitis. Natural history and evaluation of prednisolone therapy","volume":"74","author":"Helman","year":"1971","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jceh.2022.02.001_bib148","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.jceh.2016.07.003","article-title":"Pharmacologic treatment of alcoholic hepatitis: examining outcomes based on disease severity stratification","volume":"6","author":"Owens","year":"2016","journal-title":"J\u00a0Clin Exp Hepatol"},{"key":"10.1016\/j.jceh.2022.02.001_bib149","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1056\/NEJM198412063112302","article-title":"Short-term and long-term survival in patients with alcoholic hepatitis treated with oxandrolone and prednisolone","volume":"311","author":"Mendenhall","year":"1984","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jceh.2022.02.001_bib150","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1056\/NEJMoa1412278","article-title":"Prednisolone or pentoxifylline for alcoholic hepatitis","volume":"372","author":"Thursz","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jceh.2022.02.001_bib151","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.cgh.2013.06.013","article-title":"Alcoholic hepatitis: current challenges and future directions","volume":"12","author":"Singal","year":"2014","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2022.02.001_bib152","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.gtc.2011.06.008","article-title":"Alcoholic hepatitis: prognostic models and treatment","volume":"40","author":"Singal","year":"2011","journal-title":"Gastroenterol Clin N Am"},{"key":"10.1016\/j.jceh.2022.02.001_bib153","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1002\/hep.21607","article-title":"The Lille model: a new tool for therapeutic strategy in patients with severe alcoholic hepatitis treated with steroids","volume":"45","author":"Louvet","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2022.02.001_bib154","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/ar146","article-title":"The risk of upper gastrointestinal complications associated with nonsteroidal anti-inflammatory drugs, glucocorticoids, acetaminophen, and combinations of these agents","volume":"3","author":"Garcia Rodr\u00edguez","year":"2001","journal-title":"Arthritis Res"},{"key":"10.1016\/j.jceh.2022.02.001_bib155","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1097\/MEG.0b013e328355cce0","article-title":"Hepatitis C virus infection in alcoholic hepatitis: prevalence patterns and impact on in-hospital mortality","volume":"24","author":"Singal","year":"2012","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2022.02.001_bib156","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1002\/lt.21396","article-title":"Steroid avoidance in liver transplantation: meta-analysis and meta-regression of randomized trials","volume":"14","author":"Segev","year":"2008","journal-title":"Liver Transplant"},{"key":"10.1016\/j.jceh.2022.02.001_bib157","doi-asserted-by":"crossref","first-page":"11929","DOI":"10.3748\/wjg.v20.i34.11929","article-title":"Alcoholic hepatitis and concomitant hepatitis C virus infection","volume":"20","author":"Shoreibah","year":"2014","journal-title":"World J Gastroenterol"},{"issue":"1 suppl l","key":"10.1016\/j.jceh.2022.02.001_bib158","doi-asserted-by":"crossref","first-page":"S38","DOI":"10.1016\/j.jhep.2015.03.006","article-title":"Trends in the management and burden of\u00a0alcoholic liver disease","volume":"62","author":"Mathurin","year":"2015","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2022.02.001_bib159","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1053\/j.gastro.2009.04.062","article-title":"Infection in patients with severe alcoholic hepatitis treated with steroids: early response to therapy is the key factor","volume":"137","author":"Louvet","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jceh.2022.02.001_bib160","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1002\/hep.27779","article-title":"Systemic inflammatory response and serum lipopolysaccharide levels predict multiple organ failure and death in alcoholic hepatitis","volume":"62","author":"Michelena","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2022.02.001_bib161","doi-asserted-by":"crossref","first-page":"3","DOI":"10.21037\/tgh.2020.02.18","article-title":"Gut microbiome changes in Nonalcoholic fatty liver disease & alcoholic liver disease","volume":"6","author":"Kwong","year":"2021","journal-title":"Transl Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2022.02.001_bib162","doi-asserted-by":"crossref","first-page":"686","DOI":"10.3350\/cmh.2020.0145","article-title":"Emerging medical therapies for severe alcoholic hepatitis","volume":"26","author":"Tornai","year":"2020","journal-title":"Clin Mol Hepatol"},{"key":"10.1016\/j.jceh.2022.02.001_bib163","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1002\/hep.31178","article-title":"Fecal microbiome distinguishes alcohol consumption from alcoholic hepatitis but does not discriminate disease severity","volume":"72","author":"Smirnova","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2022.02.001_bib164","doi-asserted-by":"crossref","first-page":"2771","DOI":"10.1038\/s41598-020-59535-w","article-title":"A\u00a0microbial signature identifies advanced fibrosis in patients with chronic liver disease mainly due to NAFLD","volume":"10","author":"Dong","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.jceh.2022.02.001_bib165","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1002\/hep.30832","article-title":"Intestinal fungal dysbiosis and systemic immune response to fungi in patients with alcoholic hepatitis","volume":"71","author":"Lang","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2022.02.001_bib166","first-page":"152","article-title":"Infections in severe alcoholic hepatitis","volume":"30","author":"Karakike","year":"2017","journal-title":"Ann Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2022.02.001_bib167","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1007\/s15010-008-7314-x","article-title":"Multilumen central\u00a0venous catheters increase risk for catheter-related bloodstream infection: prospective surveillance study","volume":"36","author":"Templeton","year":"2008","journal-title":"Infection"},{"key":"10.1016\/j.jceh.2022.02.001_bib168","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/S0168-8278(88)80483-5","article-title":"A\u00a0randomized controlled study of peripheral parenteral nutrition in moderate and severe alcoholic hepatitis","volume":"7","author":"Simon","year":"1988","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2022.02.001_bib169","doi-asserted-by":"crossref","DOI":"10.14309\/ajg.0000000000001611","article-title":"Primary norfloxacin prophylaxis for APASL-defined acute-on-chronic liver failure: a placebo-controlled double-blind randomized trial","author":"Kulkarni","year":"2022","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jceh.2022.02.001_bib171","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.toxrep.2021.02.010","article-title":"Alcohol-associated liver disease: a review on its pathophysiology, diagnosis and drug therapy","volume":"8","author":"Subramaniyan","year":"2021","journal-title":"Toxicol Rep"},{"key":"10.1016\/j.jceh.2022.02.001_bib172","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1056\/NEJMoa1101214","article-title":"Glucocorticoids plus N-acetylcysteine in severe alcoholic hepatitis","volume":"365","author":"Nguyen-Khac","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jceh.2022.02.001_bib173","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1053\/gast.2000.20189","article-title":"Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: a double-blind, placebo-controlled trial","volume":"119","author":"Akriviadis","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jceh.2022.02.001_bib174","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1053\/j.gastro.2010.01.040","article-title":"Pentoxifylline does not decrease short-term mortality but does reduce complications in patients with advanced cirrhosis","volume":"138","author":"Lebrec","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jceh.2022.02.001_bib175","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.jceh.2015.06.005","article-title":"Of pentoxifylline and steroids for alcoholic hepatitis - has the last word been said?","volume":"5","author":"Role","year":"2015","journal-title":"J\u00a0Clin Exp Hepatol"},{"key":"10.1016\/j.jceh.2022.02.001_bib176","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1001\/jama.2013.276300","article-title":"Prednisolone with vs without pentoxifylline and survival of patients with severe alcoholic hepatitis","volume":"310","author":"Mathurin","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.jceh.2022.02.001_bib177","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.jhep.2007.10.010","article-title":"Early switch to pentoxifylline in patients with severe alcoholic hepatitis is inefficient in non-responders to corticosteroids","volume":"48","author":"Louvet","year":"2008","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2022.02.001_bib178","doi-asserted-by":"crossref","first-page":"3726","DOI":"10.1007\/s10620-020-06142-4","article-title":"A\u00a0combination of N-acetylcysteine and prednisone has No benefit over prednisone alone in severe alcoholic hepatitis: a retrospective analysis","volume":"65","author":"Amjad","year":"2020","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jceh.2022.02.001_bib179","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1056\/NEJM198812153192401","article-title":"Efficacy of oral N-acetylcysteine in the treatment of acetaminophen overdose. Analysis of the national multicenter study (1976 to 1985)","volume":"319","author":"Smilkstein","year":"1988","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jceh.2022.02.001_bib180","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.jhep.2010.05.030","article-title":"Enteral nutrition with or without N-acetylcysteine in the treatment of severe acute alcoholic hepatitis: a randomized multicenter controlled trial","volume":"53","author":"Moreno","year":"2010","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2022.02.001_bib181","article-title":"Meta-analysis and systematic review of primary renal tubular acidosis in patients with autoimmune hepatitis and alcoholic hepatitis","volume":"13","author":"Gadour","year":"2021","journal-title":"Cureus"},{"key":"10.1016\/j.jceh.2022.02.001_bib182","doi-asserted-by":"crossref","first-page":"54","DOI":"10.4103\/0253-7613.106436","article-title":"Survival benefits of terlipressin and non-responder state in hepatorenal syndrome: a meta-analysis","volume":"45","author":"Hiremath","year":"2013","journal-title":"Indian J Pharmacol"},{"key":"10.1016\/j.jceh.2022.02.001_bib183","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/S0140-6736(05)74933-3","article-title":"Improvement in renal function in hepatorenal syndrome with N-acetylcysteine","volume":"353","author":"Holt","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.jceh.2022.02.001_bib184","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/j.jhep.2009.02.002","article-title":"Endothelin-receptor antagonist\/N-acetylcysteine combination in type 1 hepatorenal syndrome","volume":"50","author":"Izzedine","year":"2009","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2022.02.001_bib185","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1053\/gast.2002.37303","article-title":"Terlipressin-induced vasoconstriction reversed with N-acetylcysteine: a case for combined use in hepatorenal syndrome?","volume":"123","author":"Sen","year":"2002","journal-title":"Gastroenterology"},{"issue":"Suppl 1","key":"10.1016\/j.jceh.2022.02.001_bib186","doi-asserted-by":"crossref","first-page":"A233","DOI":"10.1136\/gut.2011.239301.492","article-title":"Is histology required for the diagnosis of alcoholic hepatitis? a review of published randomised controlled trials","volume":"60","author":"Hamid","year":"2011","journal-title":"Gut"},{"key":"10.1016\/j.jceh.2022.02.001_bib187","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1111\/apt.16559","article-title":"Letter: the diagnostic and prognostic significance of liver histology in alcoholic hepatitis\u2014authors\u2019 reply","volume":"54","author":"Forrest","year":"2021","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jceh.2022.02.001_bib188","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.jhep.2007.05.001","article-title":"Transjugular liver biopsy--indications, adequacy, quality of specimens, and complications--a systematic review","volume":"47","author":"Kalambokis","year":"2007","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2022.02.001_bib189","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1007\/s00261-007-9357-3","article-title":"Transjugular liver biopsy using ultrasonographic guidance for jugular vein puncture and an automated device for hepatic tissue sampling: a retrospective analysis of 200 consecutive cases","volume":"33","author":"Soyer","year":"2008","journal-title":"Abdom Imag"},{"key":"10.1016\/j.jceh.2022.02.001_bib190","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1007\/s11547-008-0311-4","article-title":"Role of transjugular liver biopsy in the diagnostic and therapeutic management of patients with severe liver disease","volume":"113","author":"Esposito","year":"2008","journal-title":"Radiol Med"},{"key":"10.1016\/j.jceh.2022.02.001_bib191","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.cld.2021.03.003","article-title":"Diagnosis of alcohol-associated hepatitis: when is liver biopsy required?","volume":"25","author":"Arab","year":"2021","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.jceh.2022.02.001_bib192","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.cld.2018.09.013","article-title":"Alcohol-associated cirrhosis","volume":"23","author":"Lucey","year":"2019","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.jceh.2022.02.001_bib193","doi-asserted-by":"crossref","first-page":"115","DOI":"10.3350\/cmh.2017.0018","article-title":"Life-sustaining treatment and palliative care in patients with liver cirrhosis - legal, ethical, and practical issues","volume":"23","author":"Kim","year":"2017","journal-title":"Clin Mol Hepatol"},{"key":"10.1016\/j.jceh.2022.02.001_bib194","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1089\/jpm.2017.0656","article-title":"Palliative care and hospice interventions in decompensated cirrhosis and hepatocellular carcinoma: a rapid review of literature","volume":"21","author":"Mudumbi","year":"2018","journal-title":"J\u00a0Palliat Med"},{"key":"10.1016\/j.jceh.2022.02.001_bib195","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1089\/jpm.2019.0501","article-title":"Palliative care and hospice referrals in patients with decompensated cirrhosis: what factors are important?","volume":"23","author":"Holden","year":"2020","journal-title":"J\u00a0Palliat Med"},{"key":"10.1016\/j.jceh.2022.02.001_bib196","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.cgh.2013.08.027","article-title":"Patients with cirrhosis and denied liver transplants rarely receive adequate palliative care or appropriate management","volume":"12","author":"Poonja","year":"2014","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2022.02.001_bib197","series-title":"Vaccination of adults with liver disease","year":"2021"},{"key":"10.1016\/j.jceh.2022.02.001_bib202","series-title":"CDC statement on ACIP booster recommendations","year":"2021"}],"container-title":["Journal of Clinical and Experimental Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0973688322000226?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0973688322000226?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T06:07:58Z","timestamp":1760854078000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0973688322000226"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":194,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["S0973688322000226"],"URL":"https:\/\/doi.org\/10.1016\/j.jceh.2022.02.001","relation":{},"ISSN":["0973-6883"],"issn-type":[{"value":"0973-6883","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Current Medical Treatment for Alcohol-Associated Liver Disease","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical and Experimental Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jceh.2022.02.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Indian National Association for Study of the Liver. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}